Home > Insider Trading > Filing (0001209191-18-042325)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
917520	Integra Lifesciences Holdings Corp	IART	Laboratory Analytical Instruments (3826)	510317849

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1187574	Stuart Essig	311 C Enterprise Drive Plainsboro NJ 08536		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2018-07-09	120,100	$21.12	1,539,019	No	4	M	Direct
Common Stock	Disposition	2018-07-09	120,100	$64.08	1,418,919	No	4	S	Direct
Common Stock	Acquisiton	2018-07-10	39,652	$21.12	1,458,571	No	4	M	Direct
Common Stock	Disposition	2018-07-10	39,652	$63.79	1,418,919	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Non-Qualified Stock Option (right to buy)	Disposition	2018-07-09	120,100	$0.00	120,100	$21.12
Common Stock	Non-Qualified Stock Option (right to buy)	Disposition	2018-07-10	39,652	$0.00	39,652	$21.12

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
140,876		2018-08-14	No	4	M	Direct
101,224		2018-08-14	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	608,700	Indirect	By GRAT

Footnotes

The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person.
The price shown above represents the weighted average price of the shares sold. The range of sale prices was $64 to $64.40
The price shown above represents the weighted average price of the shares sold. The range of sale prices was $63.50 to $64.44.
25% of the option grant vested on 8/14/2009 (the first anniversary of the grant date of 8/14/2008), and the remaining 75% vested monthly thereafter over 36 months.
This stock option was previously reported as covering 130,488 shares of common stock at an exercise price of $42.24 per share. In accordance with the terms of the stock option plan, the exercise price of the option and number of shares subject to the option have been adjusted to reflect the two-for-one stock split that occurred on December 21, 2016.